DexCom, Inc.
DXCM
$73.43
-$0.95-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.60% | 14.21% | 9.30% | 9.11% | 11.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.60% | 14.21% | 9.30% | 9.11% | 11.34% |
| Cost of Revenue | 16.64% | 22.17% | 20.94% | 19.04% | 19.60% |
| Gross Profit | 14.92% | 9.27% | 2.39% | 3.23% | 6.52% |
| SG&A Expenses | 0.40% | 2.77% | 2.41% | 5.65% | 8.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.24% | 12.39% | 11.07% | 11.59% | 13.50% |
| Operating Income | 51.97% | 23.84% | 0.84% | -2.92% | 0.38% |
| Income Before Tax | 53.51% | 28.92% | -2.83% | -6.12% | -0.20% |
| Income Tax Expenses | 89.83% | 277.65% | 51.86% | 40.62% | -21.37% |
| Earnings from Continuing Operations | 45.14% | 5.86% | -14.30% | -16.28% | 6.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.14% | 5.86% | -14.30% | -16.28% | 6.41% |
| EBIT | 51.97% | 23.84% | 0.84% | -2.92% | 0.38% |
| EBITDA | 42.30% | 21.62% | 4.12% | 1.10% | 4.34% |
| EPS Basic | 46.45% | 5.66% | -14.95% | -17.86% | 4.25% |
| Normalized Basic EPS | 54.99% | 28.95% | -3.48% | -7.86% | -2.20% |
| EPS Diluted | 46.92% | 7.71% | -11.97% | -14.00% | 8.69% |
| Normalized Diluted EPS | 56.25% | 31.28% | -0.12% | -3.31% | 2.51% |
| Average Basic Shares Outstanding | -0.84% | -0.18% | 0.51% | 1.78% | 1.95% |
| Average Diluted Shares Outstanding | -1.72% | -1.80% | -2.60% | -2.94% | -2.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |